Would setting up a national network of ‘health clusters’ enable the life science and pharmaceutical sectors to best develop and manufacture vaccines, diagnostic tests and equipment? Richard Williams explains the why, where who and how.
In a time of deep uncertainty for communities and businesses across the UK, the unprecedented and collaborative government and industry response to the Coronavirus pandemic needs to be recognised. It’s heart-warming to see so many people and organisations stepping up to join in the national effort to deliver vital supplies in local communities and manufacture…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
